- We will send in 10–14 business days.
/images/books/13966358/9781774912652.jpg)
- Publisher: Apple Academic Press
- ISBN-10: 1774912651
- ISBN-13: 9781774912652
- Format: 15.2 x 22.9 x 1.9 cm, hardcover
- Language: English
- SAVE -10% with code: EXTRA
Plant-Derived Anticancer Drugs in the Omics Era (e-book) (used book) | bookbook.eu
Reviews
Description
The current anti-cancer synthetic medicines are inefficient and unsafe. The plants-based lead molecules such as taxol, camptothecin, podophyllotoxins, vinblastine, vincristine, homoharringtonine and numerous other anticancer compounds from Nature's arsenal are potentially safe and powerful alternative means that effectively fight against cancer.
The volume looks at a variety of medicinal plants and approaches that have beneficial results against cancer. Topics include Unani approaches of anticancer plants, genetic engineering and CRISPR/CAS-mediated editing to enhance anticancer potential, computational approaches used in anticancer plants, and more. The volume also examines the metabolomics of plants that give them anti-cancer properties.
This volume, Plant-Derived Anticancer Drugs in the OMICS Era: Biosynthesis, Function, and Applications, will be valuable to cancer researchers and drug developers among others.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 19d.18:17:05
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: Apple Academic Press
- ISBN-10: 1774912651
- ISBN-13: 9781774912652
- Format: 15.2 x 22.9 x 1.9 cm, hardcover
- Language: English English
The current anti-cancer synthetic medicines are inefficient and unsafe. The plants-based lead molecules such as taxol, camptothecin, podophyllotoxins, vinblastine, vincristine, homoharringtonine and numerous other anticancer compounds from Nature's arsenal are potentially safe and powerful alternative means that effectively fight against cancer.
The volume looks at a variety of medicinal plants and approaches that have beneficial results against cancer. Topics include Unani approaches of anticancer plants, genetic engineering and CRISPR/CAS-mediated editing to enhance anticancer potential, computational approaches used in anticancer plants, and more. The volume also examines the metabolomics of plants that give them anti-cancer properties.
This volume, Plant-Derived Anticancer Drugs in the OMICS Era: Biosynthesis, Function, and Applications, will be valuable to cancer researchers and drug developers among others.
Reviews